Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 19, 2018

Study Completion Date

March 6, 2018

Conditions
Multiple Myeloma
Interventions
DRUG

Melphalan

Melphalan will be administered at the same schedule and dose intensity as those of the last PI-containing treatment the patient failed (it varies with each patient).

DRUG

Prednisone

Prednisone will be administered at the same schedule and dose intensity as those of the last PI-containing treatment the patient failed (it varies with each patient).

DRUG

Cyclophosphamide

Cyclophosphamide will be administered at the same schedule and dose intensity as those of the last PI-containing treatment the patient failed (it varies with each patient).

DRUG

Dexamethasone

Dexamethasone will be administered at the same schedule and dose intensity as those of the last PI-containing treatment the patient failed (it varies with each patient).

DIETARY_SUPPLEMENT

Ascorbic acid

Vitamin C will be administered at the same schedule and dose intensity as those of the last PI-containing treatment the patient failed (it varies with each patient).

DRUG

PLD

Pegylated liposomal doxorubicin will be administered at the same schedule and dose intensity as those of the last PI-containing treatment the patient failed (it varies with each patient).

DRUG

Lenalidomide

Lenalidomide will be administered at the same schedule and dose intensity as those of the last PI-containing treatment the patient failed (it varies with each patient).

DRUG

Pomalidomide

Pomalidomide will be administered at the same schedule and dose intensity as those of the last PI-containing treatment the patient failed (it varies with each patient).

Trial Locations (12)

31792

Lewis Hall Singletary Oncology Center, Thomasville

32003

Cancer Specialists of North Florida, Fleming Island

39401

Hattiesburg Clinic Hematology/Oncology, Hattiesburg

60714

Oncology Specialists, SC, Niles

90069

James Berenson, MD, Inc, West Hollywood

92024

California Cancer Associates for Research & Excellence (cCARE), Encinitas

92262

Comprehensive Cancer Center at Desert Regional Medical Center, Palm Springs

92708

Robert A. Moss, MD, FACP, Inc, Fountain Valley

93309

Comprehensive Blood and Cancer Center, Bakersfield

93720

cCARE Fresno, Fresno

94520

John Muir Health Clinical Research Center, Concord

98502

Vista Oncology, Olympia

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Oncotherapeutics

INDUSTRY